Our Team

photo anirban ghoshTel.: (506) 869-2909
Fax: (506) 862-7571
This email address is being protected from spambots. You need JavaScript enabled to view it.

1990-1992 MSc Life Science, Jawaharlal Nehru University, New Delhi, India.
1992-1997 Ph.D Jawaharlal Nehru University, New Delhi, India: Molecular Parasitology and vaccine research.

1998-1999 Exchange Visitor Research Fellow University of Kentucky: B cell receptor signaling of both normal and malignant B cells.

1999-2001 Postdoctoral Fellow Institute of Parasitology, McGill University: Vaccine research and Molecular Parasitology.

2001-2005 Faculty Lecturer / Research Associate Department of Microbiology and Immunology, McGill University: intronic splice variant of p53, human papillomavirus, Vaccine and Molecular Parasitology research.

2006-2009 Senior Research Associate Cross Cancer Institute University of Alberta: Aberrant splice variants in Multiple Myeloma and Waldenstrom's Macroglobulinemia.

University affiliation :

Adjunct professor at the department of chemistry and biochemistry at Université de Moncton.

Research interests

Dr. Ghosh's current research mainly focuses on development of clinically-adaptable capturing technologies of exosome or extracellular vesicles (EVs) for diagnostic as well fundamental research. EVs are membrane-encapsulated nano-vesicles (30 to 300 nm) that transport cargoes of active molecules to proximal, distal cells via body fluids. Secreted EVs also contain real-time information on the physiological and pathological status of their cells of origin and can be used for minimally invasive early detection and diagnosis of disease from various body fluids ushering in the concept of a "surgery-less biopsy". Though very promising, the development of EVs-capture technologies has been hampered by the current enrichment/isolation methods of EVs where techniques like ultracentrifugation are viewed as bottle-necks for the advancement of clinical applications and antibody based capture methods lack specificity. Dr. Ghosh's research discovered and validated EVs capture technologies which will have wide application in EV based therapy and/or diagnostics not only for cancer and other human diseases but also for applications in animal care/ food industries.

Dr. Ghosh's research also focus on developing Lab-On-Chip based Bio-Micro-Electro-Mechanical Systems (BioMEMS) to adapt our proprietary EVs-capture technologies suitable for next-generation diagnostic platforms. These platforms have wide scope and potential for point-of-care early detection of many diseases and infections integrated to one Chip of human and animal health and for other potential use in food quality controls.

Dr. Ghosh's research also focuses on the biology of hyaluronic acid in cancer initiation and progression.


Archived Articles

btn campain EN
Atlantic Cancer Research Institute 
Pavillon Hôtel-Dieu
35, Providence Street
Moncton, NB E1C 8X3 Canada

Tel.: 506-862-7512
Fax.: 506-862-7571

Cover page
Our annual report
Download PDF bullet blanc

The Atlantic Cancer Research Institute

 (ACRI) is a non-profit organization founded in late 1998 and housed at the Dr. Georges-L.-Dumont University Hospital Centre in Moncton. Thanks to its unique expertise, ACRI has become a true centre of excellence in cancer research.

Our Partners

logo excipio logo chudumont logo soricimedlogo neplogo ccslogo umonctonlogo unblogo vitalitelogo conceptiaCRS logoNBHRF logoMerck Logo.svg